| Synonyms: | |
| Status: | Approved (1995) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | M03AC11 |
| UNII: | QX62KLI41N |
Structure
| InChI Key | YXSLJKQTIDHPOT-LJCJQEJUSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C53H72N2O12+2 |
| Molecular Weight | 929.16 |
| AlogP | 8.07 |
| Hydrogen Bond Acceptor | 12.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 24.0 |
| Polar Surface Area | 126.44 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 4.0 |
| Heavy Atoms | 67.0 |
Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Delayed Emergence from Anesthesia | Phase 4 | ClinicalTrials |
| Fasciculation | Phase 3 | ClinicalTrials |
| Agnosia | Phase 4 | ClinicalTrials |
| Postoperative Complications | Phase 4 | ClinicalTrials |
| Acute Lung Injury; Critical Illness; Paralysis; Respiratory Distress Syndrome, Adult; Respiratory Distress Syndrome, Newborn; Respiratory Insufficiency | Phase 4 | ClinicalTrials |
| Fasciculation; Myalgia | Phase 3 | ClinicalTrials |
| Delayed Emergence from Anesthesia; Postoperative Complications | Phase 4 | ClinicalTrials |
Related Entries
Scaffolds
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 96946-41-7 |
| ChEBI | 140621 |
| ChEMBL | CHEMBL1201248 |
| DrugBank | DB00565 |
| DrugCentral | 661 |
| EPA CompTox | DTXSID60873212 |
| FDA SRS | QX62KLI41N |
| Human Metabolome Database | HMDB0240286 |
| PubChem | 62887 |
| SureChEMBL | SCHEMBL13057748 |
| ZINC | ZINC000238809664 |
CONTENTS